Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $214.20 | Total: $1,071.00 |
| 1 | 10 | $181.44 | Total: $1,814.40 |
| 1 | 25 | $153.72 | Total: $3,843.00 |
| 1 | 50 | $131.04 | Total: $6,552.00 |
| 1 | 100 | $113.40 | Total: $11,340.01 |
Overview
Orbofiban TFA is an orally active GPIIbIIIa platelet receptor antagonist with inhibitory effects on platelet aggregation for the study of unstable coronary syndromes.
Chemical Properties
| Molecular Formula | C19H24F3N5O6 |
| Molecular Weight | 475.42 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C(OCC)CCNC(=O)NC1C(=O)N(C2=CC=C(C=C2)C(=N)N)CC1.O=C(O)C(F)(F)F |
Storage and Handling
0C Short Term, -20C Long Term
References
Nicholson NS, Abood NA, Panzer-Knodle SG, et al. Orbofiban an orally active GPIIbIIIa platelet receptor antagonist. Med Res Rev. 2001;21[3] 211-226.